Business
FIRST PATIENT DOSED IN MPS-I PHASE 2 CLINICAL TRIAL
FIRST PATIENT DOSED IN MPS-I PHASE 2 CLINICAL TRIAL
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":258,"tagName":"div"}]